CIPREC — Buenos Aires

Public research footprint of CIPREC, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Obesity · Atherosclerotic Cardiovascular Disease (ASCVD) · Type 2 Diabetes · Overweight

Recently updated registry entries

NCT07223593 — Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease (Recruiting)
NCT07220642 — Weight Loss in People Living With Overweight or Obesity Following Treatment With… (Active Not Recruiting)
NCT07241390 — A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CIPREC?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.